theophylline has been researched along with Cardiovascular Stroke in 80 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " The present study examined whether or not cilostazol reduces the myocardial infarct size, and investigated its mechanism in a rabbit model of myocardial infarction." | 7.77 | Cilostazol protects the heart against ischaemia reperfusion injury in a rabbit model of myocardial infarction: focus on adenosine, nitric oxide and mitochondrial ATP-sensitive potassium channels. ( Aoyama, T; Bai, Y; Iwasa, M; Minatoguchi, S; Murakami, H; Nishigaki, K; Sumi, S; Takemura, G; Uno, B; Ushikoshi, H; Yamada, Y, 2011) |
| "We report the use of the non-specific adenosine antagonist theophylline (aminophylline) during a prolonged intraoperative cardiopulmonary resuscitation (CPR) due to myocardial infarction." | 7.73 | [Theophylline (aminophylline) and asystole. Case report and a brief review of the literature]. ( Breil, M; Hoeft, A; Krep, H; Menzenbach, J, 2006) |
| "To show that second- or third-degree atrioventricular block occurring as an early complication of acute inferior myocardial infarction is mediated by adenosine." | 7.69 | Theophylline for the treatment of atrioventricular block after myocardial infarction. ( Belardinelli, L; Bertolet, BD; Hill, JA; McMurtrie, EB, 1995) |
| "We investigated the effect of acute myocardial infarction (MI) on the hepatic clearance of theophylline in rats using the coronary artery ligation model." | 7.69 | Effects of acute myocardial infarction on theophylline elimination in rats. ( Angus, PW; Ghabrial, H; Morgan, DJ; Ng, CY; Smallwood, RA, 1997) |
| "Exogenous administration of adenosine induces atrial fibrillation in up to 7." | 7.69 | Myocardial infarction related atrial fibrillation: role of endogenous adenosine. ( Belardinelli, L; Bertolet, BD; Hill, JA; Kerensky, RA, 1997) |
| " The present study examined whether or not cilostazol reduces the myocardial infarct size, and investigated its mechanism in a rabbit model of myocardial infarction." | 3.77 | Cilostazol protects the heart against ischaemia reperfusion injury in a rabbit model of myocardial infarction: focus on adenosine, nitric oxide and mitochondrial ATP-sensitive potassium channels. ( Aoyama, T; Bai, Y; Iwasa, M; Minatoguchi, S; Murakami, H; Nishigaki, K; Sumi, S; Takemura, G; Uno, B; Ushikoshi, H; Yamada, Y, 2011) |
| "We report the use of the non-specific adenosine antagonist theophylline (aminophylline) during a prolonged intraoperative cardiopulmonary resuscitation (CPR) due to myocardial infarction." | 3.73 | [Theophylline (aminophylline) and asystole. Case report and a brief review of the literature]. ( Breil, M; Hoeft, A; Krep, H; Menzenbach, J, 2006) |
| "To show that second- or third-degree atrioventricular block occurring as an early complication of acute inferior myocardial infarction is mediated by adenosine." | 3.69 | Theophylline for the treatment of atrioventricular block after myocardial infarction. ( Belardinelli, L; Bertolet, BD; Hill, JA; McMurtrie, EB, 1995) |
| "We investigated the effect of acute myocardial infarction (MI) on the hepatic clearance of theophylline in rats using the coronary artery ligation model." | 3.69 | Effects of acute myocardial infarction on theophylline elimination in rats. ( Angus, PW; Ghabrial, H; Morgan, DJ; Ng, CY; Smallwood, RA, 1997) |
| "Exogenous administration of adenosine induces atrial fibrillation in up to 7." | 3.69 | Myocardial infarction related atrial fibrillation: role of endogenous adenosine. ( Belardinelli, L; Bertolet, BD; Hill, JA; Kerensky, RA, 1997) |
| "The aims were to examine the role of adenosine receptors in the mechanism of preconditioning in a chronic rabbit model of myocardial infarction; to assess whether the preconditioning effect is blocked by an adenosine receptor antagonist, 8-phenyltheophylline; and to determine whether an adenosine A1 receptor agonist, R(-)N6-2-phenylisopropyl adenosine (R-PIA), mimics infarct size limitation by preconditioning." | 3.68 | Role of adenosine receptor activation in myocardial infarct size limitation by ischaemic preconditioning. ( Iimura, O; Miki, T; Miura, T; Shimamoto, K; Tsuchida, A, 1992) |
| "Ventricular fibrillation is a major mechanism of sudden death." | 2.36 | Catecholamine-mediated arrhythmias in acute myocardial infarction. Experimental evidence and role of beta-adrenoceptor blockade. ( Lubbe, WF; Opie, LH, 1979) |
| "Adenosine concentration was significantly increased in IPC effluent (2." | 1.40 | Remote cardioprotection by transfer of coronary effluent from ischemic preconditioned rabbit heart preserves mitochondrial integrity and function via adenosine receptor activation. ( Caldarone, CA; Callahan, J; Fu, YY; Kato, H; Leung, CH; Nielsen, JM; Redington, AN; Tropak, MB; Wang, L, 2014) |
| "Tyramine (Tyr) was intravenously administered before 30 min ischaemia in the absence or presence of bunazosin (BN, alpha1-receptor blocker) and staurosporine (ST), a protein kinase C inhibitor, respectively." | 1.33 | Alpha1-receptor or adenosine A1-receptor dependent pathway alone is not sufficient but summation of these pathways is required to achieve an ischaemic preconditioning effect in rabbits. ( Baba, K; Fujiwara, H; Kariya, T; Kawai, T; Minatoguchi, S; Takahashi, M; Takemura, G; Uno, Y; Zhang, C, 2005) |
| "(3) Treatment with acadesine (2." | 1.29 | Acadesine extends the window of protection afforded by ischaemic preconditioning. ( Burckhartt, B; Cohen, MV; Downey, JM; Mullane, KM; Tsuchida, A; Yang, XM, 1994) |
| "Adenosine receptors were blocked with 8-p-sulfophenyl theophylline (10 mg/kg intravenously), alpha 1-adrenergic receptors were selectively blocked with prazosin (0." | 1.29 | Adrenergic activation confers cardioprotection mediated by adenosine, but is not required for ischemic preconditioning. ( Chien, GL; Davis, RF; Haessler, R; Kuzume, K; Van Winkle, DM; Wolff, RA, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 27 (33.75) | 18.7374 |
| 1990's | 34 (42.50) | 18.2507 |
| 2000's | 14 (17.50) | 29.6817 |
| 2010's | 5 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, Z | 1 |
| de Wijs-Meijler, D | 1 |
| Lankhuizen, I | 1 |
| Jankowski, J | 1 |
| Jankowski, V | 1 |
| Jan Danser, AH | 1 |
| Duncker, DJ | 4 |
| Merkus, D | 1 |
| Leung, CH | 1 |
| Wang, L | 1 |
| Nielsen, JM | 1 |
| Tropak, MB | 1 |
| Fu, YY | 1 |
| Kato, H | 1 |
| Callahan, J | 1 |
| Redington, AN | 1 |
| Caldarone, CA | 1 |
| Paiva, M | 1 |
| Riksen, NP | 1 |
| Davidson, SM | 1 |
| Hausenloy, DJ | 1 |
| Monteiro, P | 1 |
| Gonçalves, L | 1 |
| Providência, L | 1 |
| Rongen, GA | 1 |
| Smits, P | 1 |
| Mocanu, MM | 1 |
| Yellon, DM | 3 |
| Vessey, DA | 1 |
| Li, L | 1 |
| Honbo, N | 1 |
| Karliner, JS | 1 |
| Bai, Y | 1 |
| Murakami, H | 1 |
| Iwasa, M | 1 |
| Sumi, S | 1 |
| Yamada, Y | 1 |
| Ushikoshi, H | 1 |
| Aoyama, T | 1 |
| Nishigaki, K | 1 |
| Takemura, G | 2 |
| Uno, B | 1 |
| Minatoguchi, S | 2 |
| Darbera, L | 1 |
| Chenoune, M | 1 |
| Lidouren, F | 1 |
| Ghaleh, B | 1 |
| Cohen, MV | 7 |
| Downey, JM | 9 |
| Berdeaux, A | 1 |
| Tissier, R | 1 |
| Uluçay, A | 1 |
| Arpacık Kargı, C | 1 |
| Aksoy, MF | 1 |
| SCHMIDT, L | 1 |
| STADLER, H | 1 |
| LECHNER, E | 1 |
| NUNEZ, H | 1 |
| NEMIR, P | 1 |
| BELLET, S | 1 |
| DOERFLER, J | 1 |
| SCHENNETTEN, FP | 1 |
| MAASSEN, J | 1 |
| FAZEKAS, JF | 1 |
| ALMAN, RW | 1 |
| TICKTIN, HE | 1 |
| EHRMANTRAUT, WR | 1 |
| SAVARESE, CJ | 1 |
| KAUFMANN, H | 1 |
| LEGOAZIOU, F | 1 |
| Asanuma, H | 3 |
| Sanada, S | 2 |
| Ogai, A | 2 |
| Minamino, T | 4 |
| Takashima, S | 3 |
| Asakura, M | 1 |
| Ogita, H | 1 |
| Shinozaki, Y | 3 |
| Mori, H | 3 |
| Node, K | 3 |
| Tomoike, H | 2 |
| Hori, M | 4 |
| Kitakaze, M | 4 |
| Das, S | 1 |
| Cordis, GA | 1 |
| Maulik, N | 1 |
| Das, DK | 1 |
| Okuda, H | 1 |
| Fujita, M | 2 |
| Hirata, A | 2 |
| Kim, J | 2 |
| Asano, Y | 1 |
| Kitamura, S | 1 |
| Baba, K | 1 |
| Zhang, C | 1 |
| Kariya, T | 1 |
| Uno, Y | 1 |
| Kawai, T | 1 |
| Takahashi, M | 1 |
| Fujiwara, H | 1 |
| Kin, H | 1 |
| Zatta, AJ | 1 |
| Lofye, MT | 1 |
| Amerson, BS | 1 |
| Halkos, ME | 1 |
| Kerendi, F | 1 |
| Zhao, ZQ | 3 |
| Guyton, RA | 1 |
| Headrick, JP | 1 |
| Vinten-Johansen, J | 4 |
| Solenkova, NV | 1 |
| Solodushko, V | 1 |
| Krep, H | 1 |
| Menzenbach, J | 1 |
| Breil, M | 1 |
| Hoeft, A | 1 |
| Wakeno, M | 1 |
| Seguchi, O | 1 |
| Okazaki, H | 1 |
| Tsukamoto, O | 1 |
| Okada, K | 1 |
| Komamura, K | 1 |
| Mochizuki, N | 1 |
| Lee, TM | 1 |
| Lin, MS | 1 |
| Chang, NC | 1 |
| Mougeot, G | 1 |
| Hugues, FC | 1 |
| Citone, C | 1 |
| Carelli, M | 1 |
| Di Marcotullio, G | 1 |
| Tubaro, M | 1 |
| Milazzotto, F | 1 |
| Lessem, J | 1 |
| Nolte, D | 1 |
| Armstrong, S | 1 |
| Ganote, CE | 1 |
| Angus, PW | 2 |
| Ng, CY | 2 |
| Ghabrial, H | 2 |
| Morgan, DJ | 2 |
| Smallwood, RA | 2 |
| Bertolet, BD | 2 |
| McMurtrie, EB | 1 |
| Hill, JA | 2 |
| Belardinelli, L | 2 |
| Bugge, E | 1 |
| Ytrehus, K | 1 |
| Williams, MW | 1 |
| Sato, H | 1 |
| Hudspeth, DA | 1 |
| McGee, DS | 2 |
| Van Wylen, DG | 1 |
| Woolfson, RG | 1 |
| Patel, VC | 2 |
| Neild, GH | 1 |
| Offstad, J | 1 |
| Kirkebøen, KA | 1 |
| Ilebekk, A | 2 |
| Downing, SE | 1 |
| Liu, GS | 2 |
| Richards, SC | 1 |
| Olsson, RA | 2 |
| Mullane, K | 1 |
| Walsh, RS | 3 |
| Hoshida, S | 1 |
| Kuzuya, T | 1 |
| Nishida, M | 1 |
| Yamashita, N | 1 |
| Oe, H | 1 |
| Kamada, T | 1 |
| Tada, M | 1 |
| Tsuchida, A | 4 |
| Daly, JJ | 1 |
| Thornton, JD | 1 |
| Baxter, GF | 1 |
| Marber, MS | 1 |
| Nakanishi, K | 1 |
| Tan, P | 1 |
| Raggi, P | 1 |
| Yang, XM | 2 |
| Burckhartt, B | 1 |
| Mullane, KM | 1 |
| Goto, M | 2 |
| Malmqvist, L | 1 |
| Nicol, P | 1 |
| Weiss, RL | 1 |
| Haessler, R | 1 |
| Kuzume, K | 2 |
| Wolff, RA | 1 |
| Chien, GL | 1 |
| Davis, RF | 1 |
| Van Winkle, DM | 2 |
| Klassen, CL | 1 |
| Ishibashi, Y | 1 |
| Herrlinger, SH | 1 |
| Pavek, TJ | 1 |
| Bache, RJ | 1 |
| Wang, P | 1 |
| Gallagher, KP | 1 |
| Funaya, H | 1 |
| Kerensky, RA | 1 |
| Gysembergh, A | 1 |
| Margonari, H | 1 |
| Loufoua, J | 1 |
| Ovize, A | 1 |
| André-Fouët, X | 1 |
| Minaire, Y | 1 |
| Ovize, M | 1 |
| Miura, T | 5 |
| Kawamura, S | 1 |
| Sakamoto, J | 2 |
| Matsuzaki, M | 1 |
| Shimamoto, K | 4 |
| Miki, T | 2 |
| Bünger, R | 1 |
| Suzuki, K | 1 |
| Grund, F | 1 |
| Sommerschild, HT | 1 |
| Lyberg, T | 1 |
| Kirkeboen, KA | 1 |
| Quinn, MJ | 1 |
| Fitzgerald, DJ | 1 |
| Liem, DA | 2 |
| van den Doel, MA | 1 |
| de Zeeuw, S | 1 |
| Verdouw, PD | 2 |
| Matsusaka, T | 1 |
| Hasebe, N | 1 |
| Jin, YT | 1 |
| Kawabe, J | 1 |
| Kikuchi, K | 1 |
| Ploeg, H | 1 |
| Kazim, S | 1 |
| Opie, LH | 2 |
| Nathan, D | 1 |
| Lubbe, WF | 2 |
| Bielawiec, M | 1 |
| Kiersnowska-Rogowska, B | 1 |
| Myśliwiec, M | 1 |
| Perzanowski, A | 1 |
| Hantson, P | 1 |
| Gautier, P | 1 |
| Vekemans, MC | 1 |
| Fievez, P | 1 |
| Renkin, J | 1 |
| Mahieu, P | 1 |
| Iimura, O | 2 |
| Ogawa, T | 1 |
| Iwamoto, T | 1 |
| Toombs, CF | 1 |
| McGee, S | 1 |
| Johnston, WE | 1 |
| Thornton, J | 1 |
| Stanley, AW | 1 |
| Ng, RH | 1 |
| Roe, C | 1 |
| Funt, D | 1 |
| Statland, BE | 1 |
| Bonk, S | 1 |
| Stocksmeier, U | 1 |
| Akiyama, K | 1 |
| Heller, A | 1 |
| Grosser, KD | 1 |
| Steger, W | 1 |
| Schneider, JA | 1 |
| Sperelakis, N | 1 |
| Aoyama, S | 1 |
| Deiwick, HJ | 1 |
| Wilke, KH | 1 |
| Knoche, I | 1 |
| Ballerini, C | 1 |
| Fontana, A | 1 |
| Huttman, DH | 1 |
| Zeller, W | 1 |
| Christ, F | 1 |
| Moritz, E | 1 |
4 reviews available for theophylline and Cardiovascular Stroke
| Article | Year |
|---|---|
CURRENT THERAPEUTIC CONCEPTS OF CEREBRAL AND MYOCARDIAL VASCULAR DISEASE.
Topics: Acetazolamide; Anticoagulants; Brain Ischemia; Cerebrovascular Disorders; Coronary Disease; Histamin | 1964 |
Ticlopidine and clopidogrel.
Topics: Adenosine Diphosphate; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Angina, Unstable; Aspirin; Bo | 1999 |
Biochemical aspects of arrhythmogenesis and ventricular fibrillation.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardia | 1979 |
Catecholamine-mediated arrhythmias in acute myocardial infarction. Experimental evidence and role of beta-adrenoceptor blockade.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Catecholamines; Cats; Coronary Disease; | 1979 |
2 trials available for theophylline and Cardiovascular Stroke
| Article | Year |
|---|---|
Radionuclide evaluation of CHF.
Topics: Adolescent; Adult; Coronary Disease; Digoxin; Female; Heart Aneurysm; Heart Failure; Hemodynamics; H | 1981 |
[Influence of xanthinol nicotinate on platelet agglutination test].
Topics: Humans; Myocardial Infarction; Nicotinic Acids; Platelet Adhesiveness; Theophylline | 1973 |
74 other studies available for theophylline and Cardiovascular Stroke
| Article | Year |
|---|---|
Blunted coronary vasodilator response to uridine adenosine tetraphosphate in post-infarct remodeled myocardium is due to reduced P1 receptor activation.
Topics: Adenosine A2 Receptor Antagonists; Adenosine Diphosphate; Animals; Coronary Vessels; Dinucleoside Ph | 2013 |
Remote cardioprotection by transfer of coronary effluent from ischemic preconditioned rabbit heart preserves mitochondrial integrity and function via adenosine receptor activation.
Topics: Adenosine; Animals; Disease Models, Animal; Ischemic Preconditioning, Myocardial; Male; Mitochondria | 2014 |
Metformin prevents myocardial reperfusion injury by activating the adenosine receptor.
Topics: Adenosine; Animals; Biological Transport; Hypoglycemic Agents; In Vitro Techniques; Male; Metformin; | 2009 |
Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioning.
Topics: Adenosine; Animals; Animals, Newborn; Cells, Cultured; In Vitro Techniques; Ischemic Preconditioning | 2009 |
Cilostazol protects the heart against ischaemia reperfusion injury in a rabbit model of myocardial infarction: focus on adenosine, nitric oxide and mitochondrial ATP-sensitive potassium channels.
Topics: Adenosine; Animals; Cardiotonic Agents; Cilostazol; Decanoic Acids; Disease Models, Animal; Drug Eva | 2011 |
Adenosine and opioid receptors do not trigger the cardioprotective effect of mild hypothermia.
Topics: Adenosine; Analgesics, Opioid; Animals; Fluorocarbons; Hypothermia, Induced; Morphine; Myocardial In | 2012 |
Acute myocardial infarction associated with Captagon use.
Topics: Amphetamines; Coronary Angiography; Diagnosis, Differential; Electrocardiography; Humans; Illicit Dr | 2012 |
[Therapy of experimental myocardial infarct with theophylline].
Topics: Humans; Myocardial Infarction; Theophylline | 1953 |
[Treatment of myocardial infarct].
Topics: Adenosine; Humans; Myocardial Infarction; Nikethamide; Theophylline | 1954 |
A comparison of the tolerance of the normal dog and the dog with myocardial infarction to an organic mercurial (mercurophylline); a study of the serum and muscle electrolytes.
Topics: Alkylmercury Compounds; Animals; Blood; Diuretics; Dogs; Drug Combinations; Electrolytes; Heart; Mus | 1954 |
[Ambulatory therapy of heart and lung infarcts with theokhellin].
Topics: Heart; Humans; Infarction; Khellin; Lung; Myocardial Infarction; Pulmonary Infarction; Theophylline | 1956 |
[HOW DOES THE HEPATOCARDIAL SYNDROME AFFECT THE CARDIOVASCULAR SYSTEM?WITH DIRECTIONS FOR DRUG AND DIET THERAPY].
Topics: Cardiovascular Diseases; Cardiovascular System; Diet; Diet Therapy; Diuretics; Heart Failure; Hepati | 1963 |
[EXPERIENCE IN THE TREATMENT OF CORONARY DISEASE WITH DIOXYPROPYLTHEOPHYLLINE AND KHELLIN].
Topics: Angina Pectoris; Coronary Disease; Khellin; Myocardial Infarction; Theophylline | 1963 |
[FAVORABLE TRIAL OF GENERAL ANESTHESIA WITH SODIUM PENTOTHAL IN A CASE OF MYOCARDIAL INFARCT].
Topics: Analgesia; Anesthesia; Anesthesia, General; Blood Pressure; Dihydroergotoxine; Electrocardiography; | 1964 |
Methotrexate and MX-68, a new derivative of methotrexate, limit infarct size via adenosine-dependent mechanisms in canine hearts.
Topics: 2-Aminoadipic Acid; Adenosine; Animals; Cardiotonic Agents; Dogs; Methotrexate; Myocardial Infarctio | 2004 |
Pharmacological preconditioning with resveratrol: role of CREB-dependent Bcl-2 signaling via adenosine A3 receptor activation.
Topics: Adenosine A3 Receptor Antagonists; Animals; Apoptosis; bcl-Associated Death Protein; Carrier Protein | 2005 |
Optimal windows of statin use for immediate infarct limitation: 5'-nucleotidase as another downstream molecule of phosphatidylinositol 3-kinase.
Topics: 5'-Nucleotidase; Adenosine Triphosphate; Androstadienes; Animals; Cardiotonic Agents; Chromones; Cor | 2004 |
Alpha1-receptor or adenosine A1-receptor dependent pathway alone is not sufficient but summation of these pathways is required to achieve an ischaemic preconditioning effect in rabbits.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adrenergic alpha-1 Rec | 2005 |
Postconditioning reduces infarct size via adenosine receptor activation by endogenous adenosine.
Topics: Adenosine; Animals; Male; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Perfusion; Puri | 2005 |
Endogenous adenosine protects preconditioned heart during early minutes of reperfusion by activating Akt.
Topics: Acetamides; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Androstadienes; An | 2006 |
[Theophylline (aminophylline) and asystole. Case report and a brief review of the literature].
Topics: Aged, 80 and over; Anesthesia, General; Atropine; Cardiopulmonary Resuscitation; Electrocardiography | 2006 |
Long-term stimulation of adenosine A2b receptors begun after myocardial infarction prevents cardiac remodeling in rats.
Topics: 2-Chloroadenosine; Acetamides; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; An | 2006 |
Inhibition of histone deacetylase on ventricular remodeling in infarcted rats.
Topics: Animals; Atrial Natriuretic Factor; Blotting, Western; Cardiomegaly; Cell Size; Collagen; Coronary V | 2007 |
[Drugs and the cardiovascular system].
Topics: Adrenergic beta-Antagonists; Anesthetics; Angina Pectoris; Animals; Anti-Arrhythmia Agents; Antineop | 1982 |
[Evaluation using dynamic ECG of the effects of reproterol (a new beta-2 adrenergic receptor agonist) on the heart conduction system].
Topics: Adrenergic beta-Agonists; Adult; Aged; Bronchodilator Agents; Drug Combinations; Drug Evaluation; El | 1984 |
[Dyspnea--what is to be done?].
Topics: Diazepam; Digoxin; Diuretics; Dyspnea; Emergencies; Epinephrine; Glucocorticoids; Humans; Lidocaine; | 1982 |
Adenosine receptor specificity in preconditioning of isolated rabbit cardiomyocytes: evidence of A3 receptor involvement.
Topics: Adenosine; Animals; Antihypertensive Agents; Cells, Cultured; Glucose; Myocardial Infarction; Myocar | 1994 |
Effects of chronic left ventricular failure on hepatic oxygenation and theophylline elimination in the rat.
Topics: Animals; Central Venous Pressure; Hemodynamics; Liver; Male; Myocardial Infarction; Organ Size; Oxid | 1995 |
Theophylline for the treatment of atrioventricular block after myocardial infarction.
Topics: Adenosine; Adult; Aged; Electrocardiography; Heart Block; Humans; Male; Middle Aged; Monitoring, Phy | 1995 |
Ischaemic preconditioning is protein kinase C dependent but not through stimulation of alpha adrenergic or adenosine receptors in the isolated rat heart.
Topics: Alkaloids; Animals; Benzophenanthridines; In Vitro Techniques; Male; Myocardial Infarction; Myocardi | 1995 |
Acadesine reduces myocardial infarct size by an adenosine mediated mechanism.
Topics: Adenosine; Aminoimidazole Carboxamide; Animals; Coronary Circulation; Extracellular Space; In Vitro | 1995 |
Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism.
Topics: Adenosine; Animals; Arginine; Lactates; Lactic Acid; Male; Myocardial Infarction; Myocardial Reperfu | 1995 |
ATP gated potassium channels in acute myocardial hibernation and reperfusion.
Topics: Adenosine Triphosphate; Animals; Glyburide; Ion Channel Gating; Myocardial Infarction; Myocardial Re | 1994 |
Evidence that the adenosine A3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart.
Topics: Adenosine; Animals; Antihypertensive Agents; Female; In Vitro Techniques; Male; Myocardial Infarctio | 1994 |
Adenosine blockade during reperfusion reverses the infarct limiting effect in preconditioned canine hearts.
Topics: Animals; Dogs; Female; Leukocyte Count; Male; Myocardial Infarction; Myocardial Ischemia; Myocardium | 1994 |
Ketamine-xylazine anaesthesia permits a KATP channel antagonist to attenuate preconditioning in rabbit myocardium.
Topics: Animals; Glyburide; Guanidines; Ketamine; Myocardial Infarction; Myocardial Ischemia; Myocardium; Pi | 1994 |
Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning.
Topics: Adenosine; Animals; Heart; Hemodynamics; Male; Myocardial Infarction; Myocardial Ischemia; Myocardia | 1994 |
A1 receptor mediated myocardial infarct size reduction by endogenous adenosine is exerted primarily during ischaemia.
Topics: Adenosine; Adrenergic alpha-1 Receptor Antagonists; Animals; Myocardial Infarction; Myocardial Ische | 1994 |
Therapeutic theophylline levels and adverse cardiac events.
Topics: Female; Humans; Middle Aged; Myocardial Infarction; Theophylline | 1994 |
Acadesine extends the window of protection afforded by ischaemic preconditioning.
Topics: Adenosine; Aminoimidazole Carboxamide; Animals; Female; Male; Myocardial Infarction; Myocardial Isch | 1994 |
Hypoxia preconditions rabbit myocardium via adenosine and catecholamine release.
Topics: Adenosine; Adrenergic alpha-Antagonists; Animals; Catecholamines; Heart; Hemodynamics; Hypoxia; In V | 1995 |
[Theophylline in acute myocardial infarction with AV block?].
Topics: Heart Block; Humans; Myocardial Infarction; Theophylline; Vasodilator Agents | 1996 |
Theophylline and atrioventricular block.
Topics: Heart Block; Humans; Myocardial Infarction; Theophylline | 1996 |
Adrenergic activation confers cardioprotection mediated by adenosine, but is not required for ischemic preconditioning.
Topics: Adenosine; Adrenergic alpha-Agonists; Animals; Ischemic Preconditioning, Myocardial; Myocardial Infa | 1996 |
Effect of temperature on myocardial infarction in swine.
Topics: Adenosine; Adenosine Deaminase; Animals; Body Temperature; Coronary Circulation; Female; Heart; Hemo | 1996 |
Effects of acute myocardial infarction on theophylline elimination in rats.
Topics: Animals; Cardiac Output; Central Venous Pressure; Male; Myocardial Infarction; Rats; Rats, Sprague-D | 1997 |
Pretreatment with endothelin-1 mimics ischemic preconditioning against infarction in isolated rabbit heart.
Topics: Alkaloids; Animals; Benzophenanthridines; Coronary Vessels; Dioxoles; Endothelin Receptor Antagonist | 1996 |
Vesnarinone limits infarct size via adenosine-dependent mechanisms in the canine heart.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Animals; Cardiotonic Agents; Dipyridamole; Dogs; | 1997 |
Myocardial infarction related atrial fibrillation: role of endogenous adenosine.
Topics: Adenosine; Aged; Atrial Fibrillation; Electrocardiography; Humans; Male; Middle Aged; Myocardial Inf | 1997 |
Attenuation of S-T segment elevation during repetitive coronary occlusions truly reflects the protection of ischemic preconditioning and is not an epiphenomenon.
Topics: Animals; Coronary Disease; Electrocardiography; Hemodynamics; Injections, Intravenous; Ischemic Prec | 1997 |
Stretch-induced protection shares a common mechanism with ischemic preconditioning in rabbit heart.
Topics: Animals; Coronary Circulation; Elasticity; Glyburide; Heart; Hematocrit; Hemodynamics; Ischemic Prec | 1998 |
Effect of protein kinase C inhibitors on cardioprotection by ischemic preconditioning depends on the number of preconditioning episodes.
Topics: Animals; Cell Membrane; Cytosol; Enzyme Inhibitors; Ischemic Preconditioning, Myocardial; Male; Myoc | 1998 |
Ecto-5'-nucleotidase is not required for ischemic preconditioning in rabbit myocardium in situ.
Topics: 5'-Nucleotidase; Adenosine Diphosphate; Adenosine Monophosphate; Animals; Blood Pressure; Enzyme Inh | 1998 |
Microembolization in pigs: effects on coronary blood flow and myocardial ischemic tolerance.
Topics: Animals; Arrhythmias, Cardiac; Coronary Circulation; Coronary Disease; Embolism; Female; Ischemic Pr | 1999 |
Role of adenosine in ischemic preconditioning in rats depends critically on the duration of the stimulus and involves both A(1) and A(3) receptors.
Topics: Acetamides; Adenosine; Analysis of Variance; Animals; Cryoprotective Agents; Dihydropyridines; Hista | 2001 |
Magnesium reduces myocardial infarct size via enhancement of adenosine mechanism in rabbits.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Analysis of Variance; Animals; Calcium; Drug Syne | 2002 |
Sites of action of adenosine in interorgan preconditioning of the heart.
Topics: Adenosine; Animals; Blood Pressure; Coronary Vessels; Ganglionic Blockers; Heart Rate; Hexamethonium | 2002 |
The behaviour of the platelet-leukocyte aggregation in thrombotic conditions.
Topics: Adult; Aged; Arteriosclerosis Obliterans; Blood Coagulation; Coronary Disease; Drug Therapy, Combina | 1975 |
Acute myocardial infarction in a young woman: possible relationship with sustained-release theophylline acute overdose?
Topics: Adult; Female; Humans; Myocardial Infarction; Risk Factors; Suicide, Attempted; Theophylline | 1992 |
Role of adenosine receptor activation in myocardial infarct size limitation by ischaemic preconditioning.
Topics: Animals; Disease Models, Animal; Hemodynamics; Male; Myocardial Infarction; Myocardium; Phenylisopro | 1992 |
Dipyridamole potentiates the myocardial infarct size-limiting effect of ischemic preconditioning.
Topics: Adaptation, Physiological; Animals; Coronary Disease; Dipyridamole; Hemodynamics; Male; Myocardial I | 1992 |
Myocardial protective effects of adenosine. Infarct size reduction with pretreatment and continued receptor stimulation during ischemia.
Topics: Adenosine; Animals; Coronary Circulation; Coronary Disease; Heart; Hemodynamics; Male; Methods; Myoc | 1992 |
Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart.
Topics: Adenosine; Animals; Female; Hemodynamics; Male; Myocardial Infarction; Myocardial Reperfusion; Purin | 1991 |
Increased activity of creatine kinase isoenzyme MB in a theophylline-intoxicated patient.
Topics: Aged; Aspartate Aminotransferases; Creatine Kinase; Diagnosis, Differential; Female; Humans; Isoenzy | 1985 |
[Do correlations exist between coffee drinking and myocardial infarction? (author's transl)].
Topics: Adolescent; Adult; Aged; Caffeine; Coffee; Female; Food Preferences; Germany, West; Health Surveys; | 1974 |
[Studies on myocardial metabolism in the ischemic heart. II. Studies by the electron spin resonance method].
Topics: Animals; Coronary Disease; Dipyridamole; Dogs; Electron Spin Resonance Spectroscopy; Epinephrine; Et | 1969 |
[Hemodynamics in patients with myocardial infarct following intravenous administration of Akrinor].
Topics: Drug Combinations; Hemodynamics; Humans; Injections, Intravenous; Myocardial Infarction; Norepinephr | 1974 |
The demonstration of energy dependence of the isoproterenol-induced transcellular Ca2+ current in isolated perfused guinea pig hearts--an explanation for mechanical failure of ischemic myocardium.
Topics: Action Potentials; Animals; Biological Transport; Caffeine; Calcium; Cell Membrane; Cell Membrane Pe | 1974 |
Effects of some coronary "vasodilators" on myocardial catecholamine.
Topics: Animals; Catecholamines; Dipyridamole; Dogs; Dopamine; Epinephrine; Ethylenediamines; Myocardial Inf | 1965 |
[Influence of "coronary dilators" on the pathological St-T segmental changes in the ECG].
Topics: Angina Pectoris; Blood Pressure; Coronary Disease; Electrocardiography; Ergoloid Mesylates; Humans; | 1967 |
[Therapeutic trial of an association of theophylline and proscillaridin A in the treatment of cor pulmonale and of some decompensated heart diseases].
Topics: Adult; Aged; Asthma; Atrial Fibrillation; Bufanolides; Chronic Disease; Diuresis; Electrocardiograph | 1971 |
[Aspirin in the treatment of myocardial infarct].
Topics: Aspirin; Bicarbonates; Blood Coagulation; Blood Sedimentation; Gastrointestinal Diseases; Hematuria; | 1971 |
[Control of fat clearance insufficiency in hyperlipemic atherosclerosis].
Topics: Arteriosclerosis; Coronary Disease; Drug Synergism; Heparin; Humans; Hyperlipidemias; Myocardial Inf | 1966 |
[On the therapy of hypotensive conditions with a new type of circulatory analeptic].
Topics: Chronic Disease; Humans; Hypotension; Myocardial Infarction; Theophylline | 1966 |